Literature DB >> 33827254

Major Reservoir for Heparin-Releasable TFPIα (Tissue Factor Pathway Inhibitor α) Is Extracellular Matrix.

Julie A Peterson1, Susan A Maroney1, Nicholas D Martinez1, Alan E Mast1,2.   

Abstract

[Figure: see text].

Entities:  

Keywords:  blood coagulation inhibitor; glycosaminoglycans; glypican; heparin; thromboplastin; thrombospondin; vascular endothelial growth factor

Mesh：

Substances：

Year:  2021        PMID： 33827254      PMCID： PMC8269748          DOI： 10.1161/ATVBAHA.120.315728

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   10.514


  59 in total

1.  Active tissue factor pathway inhibitor is expressed on the surface of coated platelets.

Authors:  Susan A Maroney; Sandra L Haberichter; Paul Friese; Maureen L Collins; Josephine P Ferrel; George L Dale; Alan E Mast
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

2.  Characterization of the binding between tissue factor pathway inhibitor and glycosaminoglycans.

Authors:  S Valentin; A Larnkjer; P Ostergaard; J I Nielsen; O Nordfang
Journal:  Thromb Res       Date:  1994-07-15       Impact factor: 3.944

3.  Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).

Authors:  P M Sandset; U Abildgaard; M L Larsen
Journal:  Thromb Res       Date:  1988-06-15       Impact factor: 3.944

4.  Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.

Authors:  N L Sanders; S P Bajaj; A Zivelin; S I Rapaport
Journal:  Blood       Date:  1985-07       Impact factor: 22.113

5.  Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture.

Authors:  C Lupu; F Lupu; U Dennehy; V V Kakkar; M F Scully
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311

Review 6.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

7.  Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.

Authors:  Lisa M Vincent; Sinh Tran; Ruzica Livaja; Tracy A Bensend; Dianna M Milewicz; Björn Dahlbäck
Journal:  J Clin Invest       Date:  2013-08-27       Impact factor: 14.808

Review 8.  Glycosaminoglycan Neutralization in Coagulation Control.

Authors:  Amélie I S Sobczak; Samantha J Pitt; Alan J Stewart
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-04-19       Impact factor: 8.311

9.  Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice.

Authors:  S A Maroney; J P Ferrel; S Pan; T A White; R D Simari; J H McVey; A E Mast
Journal:  J Thromb Haemost       Date:  2009-04-24       Impact factor: 5.824

10.  TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.

Authors:  Benedicte Stavik; Mari Tinholt; Marit Sletten; Grethe Skretting; Per Morten Sandset; Nina Iversen
Journal:  J Hematol Oncol       Date:  2013-01-15       Impact factor: 17.388
View more
  3 in total

1.  Factor V east Texas variant causes bleeding in a three-generation family.

Authors:  Julie A Peterson; Sweta Gupta; Nicholas D Martinez; Brandon Hardesty; Susan A Maroney; Alan E Mast
Journal:  J Thromb Haemost       Date:  2021-12-07       Impact factor: 5.824

2.  Intersection of regulatory pathways controlling hemostasis and hemochorial placentation.

Authors:  Masanaga Muto; Damayanti Chakraborty; Kaela M Varberg; Ayelen Moreno-Irusta; Khursheed Iqbal; Regan L Scott; Ross P McNally; Ruhul H Choudhury; John D Aplin; Hiroaki Okae; Takahiro Arima; Shoma Matsumoto; Masatsugu Ema; Alan E Mast; Elin Grundberg; Michael J Soares
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 12.779

Review 3.  Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy.

Authors:  Alan E Mast; Wolfram Ruf
Journal:  J Thromb Haemost       Date:  2022-03-27       Impact factor: 16.036
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.